C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/437 (2006.01) A61K 31/4375 (2006.01) A61K 31/519 (2006.01) A61P 25/24 (2006.01) A61P 25/28 (2006.01) C07D 471/14 (2006.01)
Patent
CA 2641670
The invention pertains to substituted quinazoline compounds of structures (I) and (II) that serve as effective phosphodiesterase (PDE) inhibitors. The invention also relates to compounds which are selective inhibitors of PDE-10. The invention further relates to intermediates for preparation of such compounds; pharmaceutical compositions comprising such compounds; and the use of such compounds in methods for treating certain central nervous system (CNS) or other disorders. The invention relates also to methods for treating neurodegenerative and psychiatric disorders, for example psychosis and disorders comprising deficient cognition as a symptom. (I, II).
La présente invention concerne des quinazolines substituées qui jouent le rôle d'inhibiteurs efficaces de phosphodiestérase (PDE). La présente invention concerne également des composés qui sont des inhibiteurs sélectifs de la PDE-10. La présente invention concerne également des intermédiaires de synthèse de tels composés; des compositions pharmaceutiques comprenant de tels composés; et l'emploi de tels composés dans des méthodes de traitement de certains troubles du système nerveux central (SNC) ou d'autres troubles. La présente invention concerne de plus des méthodes de traitement de troubles neurodégénératifs et psychiatriques, par exemple la psychose et les troubles dont l'un des symptômes est une déficience cognitive.
Allen Martin Patrick
Chappie Thomas Allen
Humphrey John Michael
Liras Spiros
Pfizer Products Inc.
Sim & Mcburney
LandOfFree
Substituted quinazolines as pde10 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted quinazolines as pde10 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinazolines as pde10 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1895704